EVOLVE-HBV (Evaluation of Vukuzazi LiVEr disease - Hepatitis B): A retrospective serosurvey of Hepatitis B Virus (HBV) infection, exposure, and vaccine-mediated immunity using archived samples from the Vukuzazi Study (2018-2020).

South Africa, 2018 - 2020

Reference ID

AHRI.EVOLVE.HBV

Producer(s)

Siyabonga Nxumalo, Lusanda Mazibuko, Nompumelelo Mkwanazi, Prof Philippa C Matthews, Prof Collins Iwuji, Dr Motswedi Anderson, Kathy Baisley, Gregory Ording-Jespersen, Mark Siedner, Emily Wong, Willem Hanekom, Vukuzazi Field Team, Sample Processing Unit, Khanyi Msomi, Theresa Smit, Dickman Gareta,

Metadata

Documentation in PDF DDI/XML JSON

Created on

Jul 14, 2026

Last modified

Jul 14, 2026

Page views

888

Downloads

In the past two weeks, have you taken any drugs (medication) for diabetes prescr (highbsugartx2wks)

Data file: vk_evolve

Overview

Valid: 871

Invalid: 1329

Type: Discrete

Decimal: 0

Width: 12

Range: 0 - 2

Format: Numeric

Value	Category	Cases
0	No	0	0%
1	Yes	46	5.3%
2		825	94.7%
Sysmiss		1329

EVOLVE-HBV (Evaluation of Vukuzazi LiVEr disease - Hepatitis B): A retrospective serosurvey of Hepatitis B Virus (HBV) infection, exposure, and vaccine-mediated immunity using archived samples from the Vukuzazi Study (2018-2020).

South Africa, 2018 - 2020

In the past two weeks, have you taken any drugs (medication) for diabetes prescr (highbsugartx2wks)

Data file: vk_evolve

Overview

Questions and instructions